Related Experiment Video
Updated: Jun 15, 2025
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
10.2K
NINJ1: A new player in multiple sclerosis pathogenesis and potential therapeutic target
Yinbin Xu1, Enhao Zhang1, Liangzhe Wei1
1Department of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China.
International Immunopharmacology
|August 28, 2024
Summary
Nerve injury-induced protein 1 (NINJ1) may drive multiple sclerosis (MS) by promoting inflammatory cell entry into the central nervous system (CNS) and exacerbating damage. Targeting NINJ1 offers a potential new therapeutic avenue for MS.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Pathogenesis of Inflammatory Diseases
Background:
- Multiple sclerosis (MS) is a chronic CNS inflammatory disease causing demyelination.
- Current MS treatments primarily use immunosuppression, with limited efficacy.
- Emerging research implicates nerve injury-induced protein 1 (NINJ1) in MS pathogenesis.
Purpose of the Study:
- To review the role of NINJ1 in multiple sclerosis (MS).
- To explore NINJ1's potential mechanisms in CNS inflammation and damage.
- To discuss NINJ1-targeted therapies for MS.
Main Methods:
- Literature review of studies on NINJ1 and MS.
- Analysis of NINJ1's proposed functions in immune cell migration and plasma membrane rupture.
- Examination of potential therapeutic strategies targeting NINJ1.
Main Results:
- NINJ1 may facilitate immune cell infiltration across the blood-brain barrier (BBB).
- NINJ1 is implicated in exacerbating neuroinflammation and tissue damage via plasma membrane rupture.
- NINJ1's role in inflammatory cell death and mediator release is highlighted.
Conclusions:
- NINJ1 is a potential key player in MS pathogenesis.
- Targeting NINJ1 could offer novel therapeutic strategies for MS.
- Further research into NINJ1's mechanisms is warranted for effective MS management.
More Related Videos
Related Concept Videos
01:24T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K